Court Square Group Launches AI-Powered Tools to Transform Clinical Operations Efficiency
Holyoke, MA — [June 11, 2025] — Court Square Group, a leading managed services technology company serving the Life Science industry, today announced the launch of several new Artificial Intelligence (AI) tools designed to streamline and enhance clinical operations. These cutting-edge solutions are now available to help life science organizations increase operational efficiency, improve data accuracy, and accelerate time to market for life-changing therapies.
Built on Court Square Group’s trusted Audit Ready, Compliant Cloud™ (ARCC) infrastructure, the new AI-powered capabilities are designed specifically for regulated environments, supporting the entire clinical lifecycle — from study start-up to regulatory submission.
“Clinical operations teams are under increasing pressure to do more with less — and do it faster,” said Keith Parent, CEO of Court Square Group. “Our new AI solutions reduce manual effort, surface actionable insights, and ultimately allow teams to focus on driving clinical innovation rather than being buried in process and paperwork.”
Court Square Group’s new AI tools include:
- Intelligent Search– Efficiently, securely, and affordably access personal or corporate content. Instant, secure, and intelligent access across all corporate files, regardless of where the data is stored and whether it is structured or unstructured.
- Streamline the Merger and Acquisition Process– Mergers and acquisitions take a significant amount of time and effort, particularly during the integration stage. Identifying and sorting through documents can take weeks and even months. Utilizing AI can significantly expedite many of the tasks involved in M&A.
- eTMF – eCTD Autoclassification– Managing and classifying documentation in clinical trials can be complex, error-prone, and inefficient. AI Auto Classification identifies and assigns meta-data, automatically classifying and filing the documents to the appropriate locations.
- AI and Statistical Computing Environment (SCE)– Domino Cloud for Life Sciences (DCLS), powered by Court Square Group’s ARCC is a fully managed, audit-ready SaaS solution. DCLS delivers an innovative AI and Statistical Computing Environment (SCE) featuring the traceability and governance required to support GxP processes.
- Generative AI– Efficiently harness and repurpose existing content scattered across organizational repositories to streamline content creation and innovation.
- Intelligent Application Decommissioning– Alleviate the burden and cost of maintaining legacy systems. Retain and leverage all the content within them in a secure yet accessible manner.
- RFP Responses – Tap into historical RFP responses to generate up to 90% of a new RFP automatically — saving you time, increasing consistency, and accelerating your path to new business.
- Audit Responses – Use AI to automatically generate first-draft audit responses based on previously submitted documentation.
Each AI tool is seamlessly integrated into the ARCC platform, ensuring full 21 CFR Part 11 compliance and aligning with GxP requirements. The AI solutions are designed to be scalable and customizable, making them ideal for start-ups, midsize firms, and global enterprises alike.
Court Square Group’s commitment to empowering those who change lives continues to drive its innovation roadmap. By combining deep life science expertise with emerging technologies, the company is enabling clinical teams to work smarter, not harder.
For more information about Court Square Group’s AI tools for life sciences, visit: https://courtsquaregroup.com/ai-for-life-science/
About Court Square Group
Court Square Group is a leading managed services technology company dedicated to empowering those who change lives. Our Audit Ready, Compliant Cloud™ (ARCC) infrastructure provides Life Science companies with the highest level of data integrity from pre-clinical to clinical and regulatory approval through manufacturing. We provide secure, compliant environments and expert support, allowing clients to focus on what they do best — bringing breakthrough therapies to market. Learn more at www.courtsquaregroup.com